Filed 06 Nov 2026
- Confident of maintaining INR45-46 EBITDA per kg for full FY27; volume growth target ~10%
- Export growth steady despite freight cost challenges; new pharma export client from Egypt expected
- Capex ~INR75-80 Cr for FY27; aiming for strong free cash flow and debt reduction
- Q2 FY27 volumes up 10.1% y-y; profits jumped 36%; EBITDA per kg INR46.5 vs INR39 last Q2
- Vibe specialty closures to start commercial production by Apr-May FY28; EBITDA margin ~30%
- EBITDA margin target INR50 in 2-3 years with new product lines contributing